|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2001-3-15
|
|
pubmed:abstractText |
Transgenic mice carrying an (A)gamma gene construct containing a -382 5' truncation of the (A)gamma gene promoter have a phenotype of hereditary persistence of fetal hemoglobin (HPFH) but, when the CACCC box of the -382(A)gamma promoter is deleted, there is no gamma gene expression in the adult mice. We used this system to investigate the mechanism whereby human HPFH mutations result in gamma gene expression in the adult. Introduction of the -198 T-->C HPFH mutation into the CACCC-less (A)gamma gene construct re-established the HPFH phenotype, indicating that this mutation increases promoter strength, most probably by establishing a novel CACCC box sequence in the -198(A)gamma region. The HPFH phenotype was also re-established when the -117 C-->T HPFH mutation was introduced into a -141(A)gamma promoter with a destroyed CACCC box, indicating that this mutation increases gamma promoter strength in the absence of the CACCC motif. The T-->A -175 HPFH mutation failed to re-establish the HPFH phenotype when the CACCC box was deleted, indicating that gamma gene expression in this mutation is CACCC box dependent. These results provide the first in vivo experimental evidence in support of mechanistic heterogeneity of the non-deletion HPFH mutants.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-11003662,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-11060036,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-1379347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-1688723,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-1689192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-1699206,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-1912570,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2041787,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2050690,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2430647,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2449926,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2449927,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2451123,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2462941,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2467208,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2472607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2474800,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2476717,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2478223,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-2481268,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-3181130,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-3349524,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-7537267,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-7539923,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-7575565,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-8246980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-8598197,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-9121456,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-9414299,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11226166-9734644
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0261-4189
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
157-64
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11226166-Animals,
pubmed-meshheading:11226166-Base Sequence,
pubmed-meshheading:11226166-Embryo, Mammalian,
pubmed-meshheading:11226166-Erythropoiesis,
pubmed-meshheading:11226166-Fetal Hemoglobin,
pubmed-meshheading:11226166-Globins,
pubmed-meshheading:11226166-Hemoglobinopathies,
pubmed-meshheading:11226166-Humans,
pubmed-meshheading:11226166-Mice,
pubmed-meshheading:11226166-Mice, Transgenic,
pubmed-meshheading:11226166-Models, Animal,
pubmed-meshheading:11226166-Phenotype,
pubmed-meshheading:11226166-Point Mutation,
pubmed-meshheading:11226166-Promoter Regions, Genetic,
pubmed-meshheading:11226166-Sequence Deletion
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Analysis of the mechanism of action of non-deletion hereditary persistence of fetal hemoglobin mutants in transgenic mice.
|
|
pubmed:affiliation |
Division of Medical Genetics, School of Medicine, University of Washington, Seattle, WA 98195, USA. gstam@u.washington.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
